◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Himadri Speciality Chemical Limited (HSCL) Net Income 2022–TTM

Name: Himadri Speciality Chemical Limited (HSCL) net income history 2022-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-11-02

Himadri Speciality Chemical Limited annual net income for fiscal TTM was ₹8.5 billion, an increase of 13.8% from ₹7.5 billion in fiscal 2026. All figures are reported results from public filings — no estimates or projections.

HSCL Annual Net Income

Net Income (annual)	TTM → 2026-09-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Net Income	₹8.5B	₹7.5B	₹5.6B	₹4.1B	₹2.2B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HSCL Quarterly Net Income

Net Income (quarterly)	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Net Income	₹2.3B	₹2.3B	₹2.0B	₹1.9B	—	₹1.8B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Net Income at Comparable Companies

ACUTAAS Net Income — Acutaas Chemicals Limited
7966 Net Income — LINTEC Corporation
4966 Net Income — C.Uyemura & Co.,Ltd.
4043 Net Income — Tokuyama Corporation
4634 Net Income — artience Co., Ltd.
8098 Net Income — Inabata & Co.,Ltd.

More HSCL metrics: Revenue · Gross Profit · Operating Income · EPS · Free Cash Flow

All HSCL financial statements → Interactive HSCL charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.